HG Shire Announces FDA Approval for Type 1 Gaucher Disease
02.03.10
HG Shire Announces FDA Approval of VPRIVTM (velaglucerase alfa for
injection) for the Treatment of Type 1 Gaucher Disease
Click here to see full press release: Press Release
HG Shire Announces FDA Approval of VPRIVTM (velaglucerase alfa for
injection) for the Treatment of Type 1 Gaucher Disease
Click here to see full press release: Press Release